Detection of Fc ‘Gamma’ R-Like Material in Cerebrospinal Fluid: A Factor Modifying the Immune Reaction?

1987 ◽  
pp. 403-410
Author(s):  
D. Karcher ◽  
W. De Smet ◽  
F. Frank ◽  
A. Lowenthal
Keyword(s):  
Cerebrospinal Fluid ◽  
Immune Reaction

scholarly journals Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates

Gene Therapy ◽  
2007 ◽  
Vol 15 (3) ◽  
pp. 233-238 ◽  
Author(s):  
E Butti ◽  
A Bergami ◽  
A Recchia ◽  
E Brambilla ◽  
D Franciotta ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Adenoviral Vector ◽  
Immune Reaction

Barrier Impairment and Immune Reaction in the Cerebrospinal Fluid

1975 ◽  
Vol 13 (4) ◽  
pp. 304-314 ◽  
Author(s):  
H. Glasner
Keyword(s):  
Cerebrospinal Fluid ◽  
Immune Reaction

scholarly journals Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Blood and Cerebrospinal Fluid Biomarkers to Treatment Approaches

2020 ◽  
Author(s):  
Vânia Maria Sabadoto Brienze ◽  
Júlio César André ◽  
Elisabete Liso ◽  
Irina Vlasova-St. Louis
Keyword(s):  
Cerebrospinal Fluid ◽  
Immune Reconstitution Inflammatory Syndrome ◽  
Immune Reconstitution ◽  
Immune Reaction ◽  
Opportunistic Pathogen ◽  
Treatment Modalities ◽  
Immune Restoration ◽  
Cerebrospinal Fluid Biomarkers ◽  
New Findings ◽  
Inflammatory Syndrome

Immune reconstitution inflammatory syndrome (IRIS) presents as an exaggerated immune reaction that occurs during dysregulated immune restoration in immunocompromised patients in late-stage HIV infection who commenced antiretroviral treatments. Virtually, any opportunistic pathogen can provoke this type of immune restoration disorders. In this review, we focus on recent development in the identification of risk factors for Cryptococcal IRIS and on advancements in our understanding of C-IRIS immunopathogenesis. We overview new findings in blood and cerebrospinal fluid which can potentially be useful in the diagnosis of cryptococcal meningitis IRIS. We assess the utility of these biomarkers to identify putative host-based targets, which may justify a clinical need for improvement in monitoring a patient’s laboratory results and adjusting treatment modalities in AIDS patients co-infected with Cryptococcus.

Sign in / Sign up

Export Citation Format

Share Document